The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulation.
This commentary discusses the non-immune effects of fingolimod on neuroimmunological diseases.
Haghikia
Aiden
A
Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstrasse 56, D-44791 Bochum, Germany.
Gold
Ralf
R
D000068876:Fingolimod Hydrochloride; D006801:Humans; D056747:Immunomodulation; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D009474:Neurons / Q000378:metabolism; D009836:Oligodendroglia / Q000378:metabolism; D011409:Propylene Glycols / Q000494:pharmacology / Q000627:therapeutic use; D049349:Receptors, Lysosphingolipid / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D049349:Receptors, Lysosphingolipid; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine
Am J Pathol. 2010 Jun;176(6):2682-94
20413685
Ann Neurol. 2008 Jan;63(1):61-71
17918267
J Neurosci Res. 1993 Dec 15;36(6):621-34
7511701
N Engl J Med. 2010 Feb 4;362(5):402-15
20089954
Nat Immunol. 2007 Dec;8(12):1295-301
18026082
Exp Neurol. 2008 Apr;210(2):681-90
18261728
J Neurosci. 2005 Feb 9;25(6):1459-69
15703400
Am J Pathol. 2009 May;174(5):1880-90
19349355
Science. 2002 Apr 12;296(5566):346-9
11923495
J Neurochem. 2003 Aug;86(4):848-59
12887683
N Engl J Med. 2010 Feb 4;362(5):387-401
20089952
Trends Neurosci. 1997 Oct;20(10):471-7
9347615
Glia. 2009 Jul;57(9):1000-13
19115396
Nat Rev Immunol. 2008 Oct;8(10):753-63
18787560
J Biol Chem. 2002 Jun 14;277(24):21453-7
11967257
Am J Pathol. 2008 Oct;173(4):1143-52
18772343